Apolipoprotein A and B (Sf 100-400) metabolism during bezafibrate therapy in hypertriglyceridemic subjects.

This study describes the effects of bezafibrate, an analogue of clofibrate, on the plasma lipid and lipoprotein profiles of 11 hypertriglyceridemic subjects and on their metabolism of apolipoproteins A-I, A-II, and B. The major action of the drug was to lower plasma triglyceride (by 58%; P less than...

Olles dieđut

Bibliográfalaš dieđut

Publikašuvnnas:	J Clin Invest
Váldodahkkit:	Shepherd, J, Packard, C J, Stewart, J M, Atmeh, R F, Clark, R S, Boag, D E, Carr, K, Lorimer, A R, Ballantyne, D, Morgan, H G
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	American Society for Clinical Investigation 1984
Fáttát:	Research Article
Liŋkkat:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC425409/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6511921/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI111643
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!